New Protocol Rapidly Detects Three Legionella Species
By LabMedica International staff writers Posted on 01 Mar 2016 |
Image: Legionella sp. colonies growing on an agar plate and illuminated using ultraviolet light to increase contrast (Photo courtesy of CDC/James Gathany).
Image: Transmission electron microscopy of Legionella pneumophila, responsible for over 90% of Legionnaires' disease cases (Photo courtesy of the CDC – US Centers for Disease Control and Prevention).
An innovative protocol has been developed for the detection of the three most prevalent Legionella species, enabling the source of the infection to be located in just eight hours.
The genus Legionella is a pathogenic group of Gram-negative bacteria that includes the species L. pneumophila, causing legionellosis and illnesses caused by Legionella include a pneumonia-type illness called Legionnaires' disease and a mild flu-like illness called Pontiac fever.
Scientists at the Polytechnic University of Valencia (UPV; Spain) initially based their investigation on a study carried out by a Japanese research group aiming to detect as many as four Legionella species simultaneously. However, the UPV team found that this approach was not viable and began devising a protocol for just three species: L. pneumophila (the bacteria responsible for 90% of human Legionella cases, L. micdadei and L. longbeachae. The protocol is considered a breakthrough that relies on the combined use of a multiplex polymerase chain reaction (Multiplex PCR) and pretreatment with propidium monoazide (PMA).
The new protocol brings detection time down from 14 days to just eight hours, which is a marked improvement on the most commonly used detection method. It can also be used successfully in very contaminated samples, where existing methods cannot. Yolanda Moreno Trigo, PhD, the senior scientist on the project, said, “We concentrated the sample, broke the bacteria in order to extract its DNA and then used Multiplex PCR to identify the different Legionella species. The Multiplex PCR amplifies the DNA of the target species, making it easier to identify them. Pretreatment with PMA allows us to immediately discard the DNA of the dead cells, which we are not interested in.”
Related Links:
Polytechnic University of Valencia
The genus Legionella is a pathogenic group of Gram-negative bacteria that includes the species L. pneumophila, causing legionellosis and illnesses caused by Legionella include a pneumonia-type illness called Legionnaires' disease and a mild flu-like illness called Pontiac fever.
Scientists at the Polytechnic University of Valencia (UPV; Spain) initially based their investigation on a study carried out by a Japanese research group aiming to detect as many as four Legionella species simultaneously. However, the UPV team found that this approach was not viable and began devising a protocol for just three species: L. pneumophila (the bacteria responsible for 90% of human Legionella cases, L. micdadei and L. longbeachae. The protocol is considered a breakthrough that relies on the combined use of a multiplex polymerase chain reaction (Multiplex PCR) and pretreatment with propidium monoazide (PMA).
The new protocol brings detection time down from 14 days to just eight hours, which is a marked improvement on the most commonly used detection method. It can also be used successfully in very contaminated samples, where existing methods cannot. Yolanda Moreno Trigo, PhD, the senior scientist on the project, said, “We concentrated the sample, broke the bacteria in order to extract its DNA and then used Multiplex PCR to identify the different Legionella species. The Multiplex PCR amplifies the DNA of the target species, making it easier to identify them. Pretreatment with PMA allows us to immediately discard the DNA of the dead cells, which we are not interested in.”
Related Links:
Polytechnic University of Valencia
Latest Molecular Diagnostics News
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing